Lassmann M - Search Results

1

Renal and Multiorgan Safety of ¹⁷⁷Lu-PSMA-617 in Patients with Metastatic Castration-Resistant Prostate Cancer in the VISION Dosimetry Substudy.

Herrmann K, Rahbar K, Eiber M, Sparks R, Baca N, Krause BJ, Lassmann M, Jentzen W, Tang J, Chicco D, Klein P, Blumenstein L, Basque JR, Kurth J. Herrmann K, et al. Among authors: lassmann m. J Nucl Med. 2024 Jan 2;65(1):71-78. doi: 10.2967/jnumed.123.265448. J Nucl Med. 2024. PMID: 38050121 Free PMC article.

2

In vivo formation of gamma-H2AX and 53BP1 DNA repair foci in blood cells after radioiodine therapy of differentiated thyroid cancer.

Lassmann M, Hänscheid H, Gassen D, Biko J, Meineke V, Reiners C, Scherthan H. Lassmann M, et al. J Nucl Med. 2010 Aug;51(8):1318-25. doi: 10.2967/jnumed.109.071357. Epub 2010 Jul 21. J Nucl Med. 2010. PMID: 20660387 Free article.

3

Clinical use of bone-targeting radiopharmaceuticals with focus on alpha-emitters.

Wieder HA, Lassmann M, Allen-Auerbach MS, Czernin J, Herrmann K. Wieder HA, et al. Among authors: lassmann m. World J Radiol. 2014 Jul 28;6(7):480-5. doi: 10.4329/wjr.v6.i7.480. World J Radiol. 2014. PMID: 25071888 Free PMC article. Review.

4

SPECT- and PET-based patient-tailored treatment in neuroendocrine tumors: a comprehensive multidisciplinary team approach.

Werner RA, Bluemel C, Lassmann M, Kudlich T, Higuchi T, Lopci E, Allen-Auerbach M, Colletti PM, Rubello D, Zatelli MC, Herrmann K. Werner RA, et al. Among authors: lassmann m. Clin Nucl Med. 2015 May;40(5):e271-7. doi: 10.1097/RLU.0000000000000729. Clin Nucl Med. 2015. PMID: 25642915 Review.

5

Biodistribution and radiation dosimetry for the chemokine receptor CXCR4-targeting probe 68Ga-pentixafor.

Herrmann K, Lapa C, Wester HJ, Schottelius M, Schiepers C, Eberlein U, Bluemel C, Keller U, Knop S, Kropf S, Schirbel A, Buck AK, Lassmann M. Herrmann K, et al. Among authors: lassmann m. J Nucl Med. 2015 Mar;56(3):410-6. doi: 10.2967/jnumed.114.151647. Epub 2015 Feb 19. J Nucl Med. 2015. PMID: 25698782 Free article.

6

Biodistribution and radiation dosimetry for a probe targeting prostate-specific membrane antigen for imaging and therapy.

Herrmann K, Bluemel C, Weineisen M, Schottelius M, Wester HJ, Czernin J, Eberlein U, Beykan S, Lapa C, Riedmiller H, Krebs M, Kropf S, Schirbel A, Buck AK, Lassmann M. Herrmann K, et al. Among authors: lassmann m. J Nucl Med. 2015 Jun;56(6):855-61. doi: 10.2967/jnumed.115.156133. Epub 2015 Apr 16. J Nucl Med. 2015. PMID: 25883128 Free PMC article.

7

Influence of CT-based attenuation correction on dopamine transporter SPECT with [(123)I]FP-CIT.

Lapa C, Spehl TS, Brumberg J, Isaias IU, Schlögl S, Lassmann M, Herrmann K, Meyer PT. Lapa C, et al. Among authors: lassmann m. Am J Nucl Med Mol Imaging. 2015 Feb 15;5(3):278-86. eCollection 2015. Am J Nucl Med Mol Imaging. 2015. PMID: 26069861 Free PMC article.

8

68Ga- and 177Lu-Labeled PSMA I&T: Optimization of a PSMA-Targeted Theranostic Concept and First Proof-of-Concept Human Studies.

Weineisen M, Schottelius M, Simecek J, Baum RP, Yildiz A, Beykan S, Kulkarni HR, Lassmann M, Klette I, Eiber M, Schwaiger M, Wester HJ. Weineisen M, et al. Among authors: lassmann m. J Nucl Med. 2015 Aug;56(8):1169-76. doi: 10.2967/jnumed.115.158550. Epub 2015 Jun 18. J Nucl Med. 2015. PMID: 26089548 Free article.

9

MIRD Pamphlet No. 26: Joint EANM/MIRD Guidelines for Quantitative 177Lu SPECT Applied for Dosimetry of Radiopharmaceutical Therapy.

Ljungberg M, Celler A, Konijnenberg MW, Eckerman KF, Dewaraja YK, Sjögreen-Gleisner K; SNMMI MIRD Committee; Bolch WE, Brill AB, Fahey F, Fisher DR, Hobbs R, Howell RW, Meredith RF, Sgouros G, Zanzonico P; EANM Dosimetry Committee; Bacher K, Chiesa C, Flux G, Lassmann M, Strigari L, Walrand S. Ljungberg M, et al. Among authors: lassmann m. J Nucl Med. 2016 Jan;57(1):151-62. doi: 10.2967/jnumed.115.159012. Epub 2015 Oct 15. J Nucl Med. 2016. PMID: 26471692 Free article.

10

DNA Damage in Peripheral Blood Lymphocytes of Thyroid Cancer Patients After Radioiodine Therapy.

Eberlein U, Scherthan H, Bluemel C, Peper M, Lapa C, Buck AK, Port M, Lassmann M. Eberlein U, et al. Among authors: lassmann m. J Nucl Med. 2016 Feb;57(2):173-9. doi: 10.2967/jnumed.115.164814. Epub 2015 Nov 12. J Nucl Med. 2016. PMID: 26564321 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

206 results

Search Page